In summary, we have revealed a molecular mechanism underlying the general requirement for JMJD1C in multiple types of leukemia with completely different oncogenic mutations and also uncovered how an enzymatic activity-independent function of JMJD1C regulates the function of a key TF. Here, TF is linked to leukemia.